Petros Pharmaceuticals Inc (PTPI)
0.68
+0.02
(+3.47%)
USD |
NASDAQ |
May 02, 10:31
Petros Pharmaceuticals Accounts Receivable (Quarterly): 2.226M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.226M |
September 30, 2023 | 2.975M |
June 30, 2023 | 2.577M |
March 31, 2023 | 2.400M |
December 31, 2022 | 2.110M |
September 30, 2022 | 3.733M |
June 30, 2022 | 5.748M |
Date | Value |
---|---|
March 31, 2022 | 3.741M |
December 31, 2021 | 2.455M |
September 30, 2021 | 1.952M |
June 30, 2021 | 2.021M |
March 31, 2021 | 6.194M |
December 31, 2020 | 5.153M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
1.952M
Minimum
Sep 2021
6.194M
Maximum
Mar 2021
3.330M
Average
2.577M
Median
Jun 2023
Accounts Receivable (Quarterly) Benchmarks
Avalo Therapeutics Inc | -- |
Spectral AI Inc | 1.312M |
Imunon Inc | -- |
Assembly Biosciences Inc | 0.043M |
iBio Inc | -- |